Psychopharmacology Maastricht

The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.

Learn More
hero-decor

Maastricht Psychedelic Symposium

On May 24, the Maastricht Psychedelic Research Team organized a mini-symposium on psychedelics. We welcomed two international speakers: Prof. dos Santos and Prof. Bouso from Brazil and Spain to discuss their ayahuasca and ibogaine research. We also had several internal speakers: presenting on mystical vs. autobiographical psychedelic experiences (Dr Kangaslampi), microdosing (Ms. Haijen), and 5-MeO-DMT (Mr. Reckweg).

Click below to watch the entire symposium

Watch the Live Stream
img-2-intro
featured study

Read about our new paper on the neurological origins of a visual psychedelic hallucination

Congratulations to Zeus Tipado on his newly published paper that introduces a new theory as to why a person experiences a visual trip on psychedelics.

Read The Paper

Participate in our studies!

We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.

View All Studies
img-2-intro

Henry Whitfeld, MSc

Psilocybin, Psychotherapy, Ideography

After being a psychological therapist with 20years experience in trauma work and mindfulness-informed approaches, I am now a researcher investigating how psychedelic experiences and psychotherapeutic protocols interact.

Janine Kox, MSc

Stress Resilience, Psychedelics, Cognitive biases

My research focuses on the effects of stress, sleep deprivation, on cognitive biases, by using the transdiagnostic rDOC approach, and see whether psychedelics such as LSD, Psilocybin and even non-hallucinogenic psychedelics can reverse these effects.

Dr. Rudy Schreiber

CNS Drug Discovery, Research Domain Criteria

I started my career in central nervous system drug discovery in 1993 and subsequently progressed from bench scientist to senior leadership roles at global pharmaceutical companies

Sarah Roche, MSc

Environment, Psilocybin, Sustainability

My PhD research focuses on psychedelic drugs as a tool to investigate the cognitive mechanisms underlying changes in sustainable behavior.

Iva Totomanova, MSc

ADHD, LSD, Microdosing

My primary research interest lies in exploring the potential of psychedelics to be used as novel treatment options for a range of psychiatric disorders.

Dr. Natasha Mason

Psychedelics, Neuroadaptations, Plasticity

My research is driven by my desire to find effective treatments for psychiatric disorders, particularly anxiety, depression, and post-traumatic stress disorder.

Dr. C. Rob Markus

Brain, Behavior, Stress

I became an expert on the relation between stress, brain (gene) vulnerability and the development of cognitive-affective complaints/disorders as well as in testing (claims about) dietary treatment/assessment methods.

Katharina Lege, MSc

Cannabinoids, Neuroimaging, Consciousness

Coming from a background of psychology and clinical neuroscience, I developed a strong interest in altered states of the mind as in mediation or yoga practices.

Prof. Arjan Blokland

Cognition, Learning & Memory, Acetylcholine

I studied Psychology at the Radboud University (Nijmegen, NL). After receiving my PhD in Maastricht in 1992, I did a post doc at the University of Cambridge in 1992.

We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.

Copyright 2024 © Psychopharmacology Department at Maastricht University, All Rights Reserved